health source semaglutide Researchers highlight the limitations and risks of US adult obesity rate drops

Most of the GLP-1 medications slow gastric emptying and reduce appetite, which can lead to lower fluid intake

This is the gold-standard therapy for people with type 1 diabetes and pre-final or end-stage renal disease if no contraindications (malignancies, chronic infections, insufficient self-management and severe cardiovascular conditions) are present

Not every side effect emerges in the first few weeks

Individual factors determine suitability

Careful medical monitoring is essential, and without meaningful changes to diet, increasing strength training, and lifestyle changes, the weight can quickly return once you stop the treatment leaving undesirable facial changes